LYVE1 anticorps (AA 271-275)
Aperçu rapide pour LYVE1 anticorps (AA 271-275) (ABIN5689389)
Antigène
Voir toutes LYVE1 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 271-275
-
Specificité
- This antibody detects endogenous level of total Lymphatic vessel endothelial hyaluronic acid receptor 1 protein.
-
Purification
- Antibodies were purified by affinity-chromatography using epitope-specific peptide.
-
Immunogène
- Lymphatic vessel endothelial hyaluronic acid receptor 1 antibody was raised against a peptide sequence around aa.271~275 (K-N-Q-Q-K) derived from Human Lymphatic vessel endothelial hyaluronic acid receptor 1.
-
-
-
-
Indications d'application
- Western Blot: 1:500~1:1000
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 mg/mL
-
Buffer
- Antibody supplied in phosphate buffered saline (without Mg2+ and Ca2+), pH 7.4, 150 mM NaCl, 0.02 % sodium azide and 50 % glycerol.
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- -20 °C
-
Stockage commentaire
- Store antibody at -20°C for up to one year.
-
-
- LYVE1 (Lymphatic Vessel Endothelial Hyaluronan Receptor 1 (LYVE1))
-
Autre désignation
- Lymphatic vessel endothelial hyaluronic acid receptor 1
-
Sujet
- Ligand-specific transporter trafficking between intracellular organelles (TGN) and the plasma membrane. Plays a role in autocrine regulation of cell growth mediated by growth regulators containing cell surface retention sequence binding (CRS). May act as an hyaluronan (HA) transporter, either mediating its uptake for catabolism within lymphatic endothelial cells themselves, or its transport into the lumen of afferent lymphatic vessels for subsequent re-uptake and degradation in lymph nodes.
-
Poids moléculaire
- 40 kDa
-
ID gène
- 10894
-
NCBI Accession
- NP_006682
-
UniProt
- Q9Y5Y7
-
Pathways
- Glycosaminoglycan Metabolic Process
Antigène
-